7,101
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Estimating the healthcare cost of overweight and obesity in South Africa

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Article: 2045092 | Received 15 Nov 2021, Accepted 15 Feb 2022, Published online: 07 Apr 2022
 

ABSTRACT

Background

Overweight and obesity are major risk factors for noncommunicable diseases. This presents a major burden to health systems and to society in South Africa. Collectively, these conditions are overwhelming public healthcare. This is happening when the country has embarked on a journey to universal health coverage, hence the need to estimate the cost of overweight and obesity.

Objective

Our objective was to estimate the healthcare cost associated with treatment of weight-related conditions from the perspective of the South African public sector payer.

Methods

Using a bottom-up gross costing approach, this study draws data from multiple sources to estimate the direct healthcare cost of overweight and obesity in South Africa. Population Attributable Fractions (PAF) were calculated and multiplied by each disease’s total treatment cost to apportion costs to overweight and obesity. Annual costs were estimated for 2020.

Results

The total cost of overweight and obesity is estimated to be ZAR33,194 million in 2020. This represents 15.38% of government health expenditure and is equivalent to 0.67% of GDP. Annual per person cost of overweight and obesity is ZAR2,769. The overweight and obesity cost is disaggregated as follows: cancers (ZAR352 million), cardiovascular diseases (ZAR8,874 million), diabetes (ZAR19,861 million), musculoskeletal disorders (ZAR3,353 million), respiratory diseases (ZAR360 million) and digestive diseases (ZAR395 million). Sensitivity analyses show that the total overweight and obesity cost is between ZAR30,369 million and ZAR36,207 million.

Conclusion

This analysis has demonstrated that overweight and obesity impose a huge financial burden on the public health care system in South Africa. It suggests an urgent need for preventive, population-level interventions to reduce overweight and obesity rates. The reduction will lower the incidence, prevalence, and healthcare spending on noncommunicable diseases.

Responsible Editor Stig Wall

Responsible Editor Stig Wall

Disclosure statement

No potential conflict of interest was reported by the author(s).

Patient involvement

No patients were involved.

Paper context

The burden of noncommunicable diseases is rising globally, and overweight and obesity are major risk factors. This study comprehensively estimates the healthcare cost associated with treatment of obesity-related conditions using gross costing approach. The study finds the burden of overweight and obesity to be huge (ZAR33,194 million) hence the need for population-level interventions to reduce obesity rates in South Africa.

Supplementary material

Supplemental data for this article can be accessed here.

Additional information

Funding

This study received funding from Bloomberg Philanthropies through the University of North Carolina, USA [grant number 5106249] and the South African Medical Research Council [grant number 23108].

Notes on contributors

Micheal Kofi Boachie

Conceived the research: KH. Costing analysis: MKB. Contributed analysis/materials: ET, MI, CKL, KH. Wrote the first draft: MKB. Provided critical review and edited drafts: MKB, ET, MI, CKL, KH. All authors approved the final version submitted.